Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion

Molecular Metabolism

Volumn 3, Issue 2, 2014, Pages 135-144

  Mattijssen, Frits ^a   Alex, Sheril ^a   Swarts, Hans J ^a   Groen, Albert K ^b   van Schothorst, Evert M ^a   Kersten, Sander ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Angptl4; Intestine; Obesity; Pancreatic lipase

Indexed keywords

ANGIOPOIETIN LIKE 4; LIPID; RECOMBINANT PROTEIN; REGULATOR PROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENZYME ACTIVITY; FAT INTAKE; FEMALE; HUMAN; LIPID ABSORPTION; LIPID METABOLISM; LIPID STORAGE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; SMALL INTESTINE ABSORPTION;

MUS;

EID: 84895806491     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.11.004     Document Type: Article

References (56)

1. Armand M. Lipases and lipolysis in the human digestive tract: where do we stand?. Current Opinion in Clinical Nutrition and Metabolic Care 2007, 10:156-164.
2. Wilde P.J., Chu B.S. Interfacial & colloidal aspects of lipid digestion. Advances in Colloid and Interface Science 2011, 165:14-22.
3. Carriere F., Barrowman J.A., Verger R., Laugier R. Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 1993, 105:876-888.
4. Whitcomb D.C., Lowe M.E. Human pancreatic digestive enzymes. Digestive Diseases and Sciences 2007, 52:1-17.
5. Brownlee I.A., Forster D.J., Wilcox M.D., Dettmar P.W., Seal C.J., Pearson J.P. Physiological parameters governing the action of pancreatic lipase. Nutrition Research Reviews 2010, 23:146-154.
6. Wang T.Y., Liu M., Portincasa P., Wang D.Q. New insights into the molecular mechanism of intestinal fatty acid absorption. European Journal of Clinical Investigation 2013, 43:1203-1223.
7. Demignot, S., Beilstein, F., Morel, E., Triglyceride-rich lipoproteins and cytosolic lipid droplets in enterocytes: key players in intestinal physiology and metabolic disorders. Biochimie. in press. http://dx.doi.org/10.1016/j.biochi.2013.07.009.
8. Iqbal J., Hussain M.M. Intestinal lipid absorption. American Journal of Physiology - Endocrinology and Metabolism 2009, 296:E1183-E1194.
9. Wang H., Eckel R.H. Lipoprotein lipase: from gene to obesity. American Journal of Physiology - Endocrinology and Metabolism 2009, 297:E271-E288.
10. Beigneux A.P., Davies B.S., Gin P., Weinstein M.M., Farber E., Qiao X., et al. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metabolism 2007, 5:279-291.
11. Davies B.S., Beigneux A.P., Barnes R.H., Tu Y., Gin P., Weinstein M.M., et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metabolism 2010, 12:42-52.
12. Mattijssen F., Kersten S. Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochimica et Biophysica Acta 2012, 1821:782-789.
13. Quagliarini F., Wang Y., Kozlitina J., Grishin N.V., Hyde R., Boerwinkle E., et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:19751-19756.
14. Wang Y., Quagliarini F., Gusarova V., Gromada J., Valenzuela D.M., Cohen J.C., et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:16109-16114.
15. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochemical and Biophysical Research Communications 2012, 424:786-792.
16. Kaplan R., Zhang T., Hernandez M., Gan F.X., Wright S.D., Waters M.G., et al. Regulation of the angiopoietin-like protein 3 gene by LXR. Journal of Lipid Research 2003, 44:136-143.
17. Inaba T., Matsuda M., Shimamura M., Takei N., Terasaka N., Ando Y., et al. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. Journal of Biological Chemistry 2003, 278:21344-21351.
18. Mandard S., Zandbergen F., van Straten E., Wahli W., Kuipers F., Muller M., et al. The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. Journal of Biological Chemistry 2006, 281:934-944.
19. Lichtenstein L., Mattijssen F., de Wit N.J., Georgiadi A., Hooiveld G.J., van der Meer R., et al. Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metabolism 2010, 12:580-592.
20. Georgiadi A., Lichtenstein L., Degenhardt T., Boekschoten M.V., van Bilsen M., Desvergne B., et al. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circulation Research 2010, 106:1712-1721.
21. Yu X., Burgess S.C., Ge H., Wong K.K., Nassem R.H., Garry D.J., et al. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:1767-1772.
22. Kroupa O., Vorrsjo E., Stienstra R., Mattijssen F., Nilsson S.K., Sukonina V., et al. Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue. BMC Physiology 2012, 12:13.
23. Sukonina V., Lookene A., Olivecrona T., Olivecrona G. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17450-17455.
24. Lafferty M.J., Bradford K.C., Erie D.A., Neher S.B. Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation. Journal of Biological Chemistry 2013, 288:28524-28534.
25. Kersten S., Lichtenstein L., Steenbergen E., Mudde K., Hendriks H.F., Hesselink M.K., et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:969-974.
26. Koliwad S.K., Kuo T., Shipp L.E., Gray N.E., Backhed F., So A.Y., et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. Journal of Biological Chemistry 2009, 284:25593-25601.
27. Staiger H., Haas C., Machann J., Werner R., Weisser M., Schick F., et al. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 2009, 58:579-589.
28. Wong H., Schotz M.C. The lipase gene family. Journal of Lipid Research 2002, 43:993-999.
29. Koster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., et al. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005, 146:4943-4950.
30. Hoevenaars F.P., Keijer J., Swarts H.J., Snaas-Alders S., Bekkenkamp-Grovenstein M., van Schothorst E.M. Effects of dietary history on energy metabolism and physiological parameters in C57BL/6J mice. Experimental Physiology 2013, 98:1053-1062.
31. Govers M.J., Van der Meet R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut 1993, 34:365-370.
32. Goudriaan J.R., Dahlmans V.E., Febbraio M., Teusink B., Romijn J.A., Havekes L.M., et al. Intestinal lipid absorption is not affected in CD36 deficient mice. Molecular and Cellular Biochemistry 2002, 239:199-202.
33. Plosch T., Kok T., Bloks V.W., Smit M.J., Havinga R., Chimini G., et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. Journal of Biological Chemistry 2002, 277:33870-33877.
34. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 2004, 5:R80.
35. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
36. Dai M., Wang P., Boyd A.D., Kostov G., Athey B., Jones E.G., et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Research 2005, 33:e175.
37. Bunger M., van den Bosch H.M., van der Meijde J., Kersten S., Hooiveld G.J., Muller M. Genome-wide analysis of PPARalpha activation in murine small intestine. Physiological Genomics 2007, 30:192-204.
38. Alex S., Lange K., Amolo T., Grinstead J.S., Haakonsson A.K., Szalowska E., et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor gamma. Molecular and Cellular Biology 2013, 33:1303-1316.
39. Korecka A., de Wouters T., Cultrone A., Lapaque N., Pettersson S., Dore J., et al. ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways. American Journal of Physiology: Gastrointestinal and Liver Physiology 2013, 304:G1025-G1037.
40. Lichtenstein L., Berbee J.F., van Dijk S.J., van Dijk K.W., Bensadoun A., Kema I.P., et al. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake. Arteriosclerosis, Thrombosis, and Vascular Biology 2007, 27:2420-2427.
41. Yoshida K., Shimizugawa T., Ono M., Furukawa H. Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. Journal of Lipid Research 2002, 43:1770-1772.
42. de la Garza A.L., Milagro F.I., Boque N., Campion J., Martinez J.A. Natural inhibitors of pancreatic lipase as new players in obesity treatment. Planta Medica 2011, 77:773-785.
43. Birari R.B., Bhutani K.K. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discovery Today 2007, 12:879-889.
44. Marchbank T., Freeman T.C., Playford R.J. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair. Digestion 1998, 59:167-174.
45. Laskowski M., Kato I. Protein inhibitors of proteinases. Annual Review of Biochemistry 1980, 49:593-626.
46. Bohe H., Bohe M., Lundberg E., Polling A., Ohlsson K. Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine. Journal of Gastroenterology 1997, 32:623-627.
47. Wang J., Ohmuraya M., Hirota M., Baba H., Zhao G., Takeya M., et al. Expression pattern of serine protease inhibitor kazal type 3 (Spink3) during mouse embryonic development. Histochemistry and Cell Biology 2008, 130:387-397.
48. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
49. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
50. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15718-15723.
51. Camp J.G., Jazwa A.L., Trent C.M., Rawls J.F. Intronic cis-regulatory modules mediate tissue-specific and microbial control of angptl4/fiaf transcription. PLoS Genetics 2012, 8:e1002585.
52. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:979-984.
53. Santas J., Espadaler J., Cune J., Rafecas M. Partially hydrolyzed guar gums reduce dietary fatty acid and sterol absorption in guinea pigs independent of viscosity. Lipids 2012, 47:697-705.
54. Vahouny G.V., Satchithanandam S., Chen I., Tepper S.A., Kritchevsky D., Lightfoot F.G., et al. Dietary fiber and intestinal adaptation: effects on lipid absorption and lymphatic transport in the rat. American Journal of Clinical Nutrition 1988, 47:201-206.
55. Alex, S., Lichtenstein, L., Dijk, W., Mensink, R.P., Tan, N.S., Kersten, S., ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract. Histochemistry and Cell Biology. in press. http://dx.doi.org/10.1007/s00418-013-1157-y.
56. Kim H.K., Youn B.S., Shin M.S., Namkoong C., Park K.H., Baik J.H., et al. Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight. Diabetes 2010, 59:2772-2780.